Created On: 2020-07-15
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 160661
Licensor Product shall mean any dosage form of a compound which is the subject of research and development as a potential human pharmaceutical product which has been recommended by Licensee and accepted by Licensors Board of Directors for development as such under the Research and Development Agreement. Such recommendations may be made on a Field of Use basis. The following compounds have been selected as the initial Licensor Products as of the date hereof: (i) Tazarotene (oral), (ii) Memantine, (iii) AGN 4310 and (iv) a compound to be selected from the RAR alpha-selective agonist class of retinoid compounds for the treatment of various cancers.
IPSCIO Record ID: 160660
Licensee Technology shall mean all Proprietary Rights licensed and/or sublicensed by Licensee and/or its Affiliates pursuant to the Technology License Agreement.
Developed Technology shall mean Proprietary Rights that (a) are first generated, conceived or reduced to practice, as the case may be, by Licensee or by any third party in the course of performing activities undertaken pursuant to this Agreement or (b) are, in any manner, acquired by, or otherwise obtained on behalf of, Licensor during the term of this Agreement from persons other than Licensee and are necessary or useful to the research, development or commercialization of Licensor Products or Pre-Selection Products.
Therapeutic Agent shall mean a drug, protein, peptide, gene, compound or other pharmaceutically active ingredient.
IPSCIO Record ID: 219094
Mucositis is the painful inflammation and ulceration of the mucous membranes lining the digestive tract, usually as an adverse effect of chemotherapy and radiotherapy treatment for cancer.